Related references
Note: Only part of the references are listed.Chronic catestatin treatment reduces atrial fibrillation susceptibility via improving calcium handling in post-infarction heart failure rats
Min Yan et al.
PEPTIDES (2023)
CBD supplementation reduces arterial blood pressure via modulation of the sympatho-chromaffin system: A substudy from the HYPER-H21-4 trial
Marko Kumric et al.
BIOMEDICINE & PHARMACOTHERAPY (2023)
Beta-blocker treatment of patients with atrial fibrillation attenuates spontaneous calcium release-induced electrical activity
Veronica Jimenez-Sabado et al.
BIOMEDICINE & PHARMACOTHERAPY (2023)
Serum catestatin levels in patients with rheumatoid arthritis
Petra Simac et al.
SCIENTIFIC REPORTS (2022)
Impact of R-Carvedilol on β2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes
Sergi Casabella-Ramon et al.
BIOMEDICINES (2022)
Serum Catestatin Levels Correlate with Ambulatory Blood Pressure and Indices of Arterial Stiffness in Patients with Primary Hypertension
Marko Kumric et al.
BIOMOLECULES (2022)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
Intracellular β1-Adrenergic Receptors and Organic Cation Transporter 3 Mediate Phospholamban Phosphorylation to Enhance Cardiac Contractility
Ying Wang et al.
CIRCULATION RESEARCH (2021)
Growth differentiation factor-15 predicts major adverse cardiac events and all-cause mortality in patients with atrial fibrillation
Stephan Nopp et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)
Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective
Josko Bozic et al.
BIOMEDICINES (2021)
Thromboembolic risk stratification in atrial fibrillation-beyond clinical risk scores
Darryl Wan et al.
REVIEWS IN CARDIOVASCULAR MEDICINE (2021)
The associations between anxiety/depression and plasma chromogranin A among healthy workers: Results from EHOP study
Ying Li et al.
JOURNAL OF OCCUPATIONAL HEALTH (2020)
Catestatin reverses the hypertrophic effects of norepinephrine in H9c2 cardiac myoblasts by modulating the adrenergic signaling
Jahangir Alam et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)
Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT-HF study
Josip A. Borovac et al.
ESC HEART FAILURE (2020)
Decreased circulating catestatin levels are associated with coronary artery disease: The emerging anti-inflammatory role
Yanjia Chen et al.
ATHEROSCLEROSIS (2019)
The cardiac autonomic nervous system: A target for modulation of atrial fibrillation
Mu Qin et al.
CLINICAL CARDIOLOGY (2019)
Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study
Josip A. Borovac et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Catestatin prevents endothelial inflammation and promotes thrombus resolution in acute pulmonary embolism in mice
Hua Chen et al.
BIOSCIENCE REPORTS (2019)
Health-related quality of life in patients with atrial fibrillation: The role of symptoms, comorbidities, and the type of atrial fibrillation
Fabienne Witassek et al.
PLOS ONE (2019)
Catestatin: A Master Regulator of Cardiovascular Functions
Sushil K. Mahata et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Catestatin Prevents Macrophage-Driven Atherosclerosis but Not Arterial Injury-Induced Neointimal Hyperplasia
Miho Kojima et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Catestatin as a Target for Treatment of Inflammatory Diseases
Elke M. Muntjewerff et al.
FRONTIERS IN IMMUNOLOGY (2018)
Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging
Maurizio Galderisi et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2017)
Glycosylated Chromogranin A in Heart Failure Implications for Processing and Cardiomyocyte Calcium Homeostasis
Anett Hellebo Ottesen et al.
CIRCULATION-HEART FAILURE (2017)
Chronic Administration of Catestatin Improves Autonomic Function and Exerts Cardioprotective Effects in Myocardial Infarction Rats
Dandan Wang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2016)
The predictive value of plasma catestatin for all-cause and cardiac deaths in chronic heart failure patients
Fen Peng et al.
PEPTIDES (2016)
Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry
Ameet Bakhai et al.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2016)
Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry
Giuseppe Boriani et al.
AMERICAN JOURNAL OF MEDICINE (2015)
The important role of catestatin in cardiac remodeling
Zheng Wu et al.
BIOMARKERS (2014)
Dominant Frequency Increase Rate Predicts Transition from Paroxysmal to Long-Term Persistent Atrial Fibrillation
Raphael P. Martins et al.
CIRCULATION (2014)
Role of the Autonomic Nervous System in Atrial Fibrillation Pathophysiology and Therapy
Peng-Sheng Chen et al.
CIRCULATION RESEARCH (2014)
Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes
Maura Greiser et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation
Torsten Christ et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The Effect of Anxiety and Depression on Symptoms Attributed to Atrial Fibrillation
Tiffany S. Thompson et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2014)
Plasma levels and diagnostic value of catestatin in patients with heart failure
Lin Liu et al.
PEPTIDES (2013)
Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy
Ziad Hijazi et al.
CIRCULATION (2012)
Recent Insights Into the Role of the Autonomic Nervous System in the Creation of Substrate for Atrial Fibrillation Implications for Therapies Targeting the Atrial Autonomic Nervous System
Rishi Arora
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2012)
Chromogranin-A: A Multifaceted Cardiovascular Role in Health and Disease
T. Angelone et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Cyclic Adenosine Monophosphate Phosphodiesterase Type 4 Protects Against Atrial Arrhythmias
Cristina E. Molina et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Catestatin is useful in detecting patients with stage B heart failure
Dan Zhu et al.
BIOMARKERS (2011)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
Is inflammation a risk factor for recurrent atrial fibrillation?
Marcelle D. Smit et al.
EUROPACE (2009)
Histopathological substrate for chronic atrial fibrillation in humans
Bich Lien Nguyen et al.
HEART RHYTHM (2009)
Mitochondrial Ion Channels and Cardioprotection
Hirofumi Nishida et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2009)
Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent:: inhibition of isoproterenol and endothelin signaling in the frog heart
Rosa Mazza et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Phospholamban Thiols Play a Central Role in Activation of the Cardiac Muscle Sarcoplasmic Reticulum Calcium Pump by Nitroxyl
Jeffrey P. Froehlich et al.
BIOCHEMISTRY (2008)
Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure
Nitish R. Mahapatra
CARDIOVASCULAR RESEARCH (2008)
Differential behaviors of atrial versus ventricular fibroblasts - A potential role for platelet-derived growth factor in atrial-ventricular remodeling differences
Brett Burstein et al.
CIRCULATION (2008)
NT-proBNP predicts rhythm stability after cardioversion of lone atrial fibrillation
Helge Moellmann et al.
CIRCULATION JOURNAL (2008)
The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism
Tommaso Angelone et al.
ENDOCRINOLOGY (2008)
Cancer patients with markedly elevated B-type natriuretic peptide may not have volume overload
Sukesh C. Burjonroppa et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2007)
Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function
Maurizio Pieroni et al.
EUROPEAN HEART JOURNAL (2007)
Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during angiotensin II induced aneurysm formation
Matthew J. Eagleton et al.
JOURNAL OF SURGICAL RESEARCH (2006)
Evidence for increased atrial sympathetic innervation in persistent human atrial fibrillation
Paul A. Gould et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2006)
Autonomic innervation and segmental muscular disconnections at the human pulmonary vein-atrial junction - Implications for catheter ablation of atrial-pulmonary vein junction
Alex Y. Tan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters
Nitish R. Mahapatra et al.
JOURNAL OF HYPERTENSION (2006)
B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure - Comparison between systolic and diastolic heart failure
Y Iwanaga et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation
E Patterson et al.
HEART RHYTHM (2005)
Defective cardiac ryanodine receptor regulation during atrial fibrillation
JA Vest et al.
CIRCULATION (2005)
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study
JL Januzzi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects
KB Helle
BIOLOGICAL REVIEWS (2004)
Altered atrial electrical restitution and heterogeneous sympathetic hyperinnervation in hearts with chronic left ventricular myocardial infarction - Implications for atrial fibrillation
Y Miyauchi et al.
CIRCULATION (2003)
β-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure
S Reiken et al.
CIRCULATION (2003)
Mechanisms of disease - The chromogranin-secretogranin family.
L Taupenot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation - Potential mechanisms for atrial thrombosis and stroke
H Cai et al.
CIRCULATION (2002)
Catecholamine effects on cardiac remodelling, oxidative stress and fibrosis in experimental heart failure
D Bonnefont-Rousselot et al.
REDOX REPORT (2002)
β-Adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure
S Reiken et al.
CIRCULATION (2001)
Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
BF Gage et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
